F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
D

Failure to Ensure Appropriate Psychotropic Use and Gradual Dose Reduction

Schenectady Center For Rehabilitation And NursingSchenectady, New York Survey Completed on 08-19-2025

Summary

The facility did not ensure that a resident’s drug regimen was free from chemical restraints and unnecessary psychotropic medication use. Resident #14, who had diagnoses including unspecified dementia with behavioral disturbance, anxiety disorder, and peripheral vascular disease, was ordered Buspirone for anxiety, Seroquel 50 mg twice daily and Seroquel 25 mg at bedtime for antipsychotic use, and oxycodone and OxyContin for severe pain. During the survey, the resident was observed multiple times appearing lethargic, asleep, or hunched over in a wheelchair during the day. Record review showed the resident had been on Seroquel since at least 10/27/2023, with prior gradual dose reduction reviews documented in 4/2024 and 10/2024. A facility psychotropic listing report stated that in 8/2025 the Seroquel dose was increased to 50 mg twice daily plus 25 mg at bedtime, and that the next gradual dose reduction was due in 5/2026, with the last reduction listed as contraindicated. A medication regimen review from 4/30/2024 documented that the resident was due for a gradual dose reduction assessment and that the contraindication reason checked was that the current dose was maintaining function and a reduction would likely cause a decline in function manifested by self-inflicted injuries. The record also showed conflicting documentation about behavioral monitoring and dose reduction attempts. The treatment administration record documented monitored behaviors on some dates in May and July 2025, but there was no documented evidence that behaviors were monitored in June 2025. A team meeting note on 5/8/2025 documented a recommendation to reduce Seroquel to 25 mg daily, while later provider notes stated the resident was stable, had no noted behaviors since admission, and was not appropriate for gradual dose reduction because of a history of hallucinations and paranoid delusions. Staff interviews indicated they could not find documented evidence that the dose had actually been lowered, only that administration times had changed, and the DON and medical director provided explanations about medication use and sedation without documenting a completed gradual dose reduction for the resident.

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Resources

Below are regulatory guidelines relevant to this citation:

See other F0605 citations
PRN Antipsychotic Order Not Limited or Reassessed
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

PRN Antipsychotic Order Not Limited or Reassessed: A resident with advanced dementia, Alzheimer’s disease, agitation, and hospice services received PRN haloperidol for agitation and delirium under an open-ended order rather than a 14-day limit. Physician documentation continued the medication but did not show an evaluation of its ongoing need or an adequate rationale for renewal, and nursing notes did not document non-pharmacological interventions before one PRN dose was given.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Lack of Behavior Monitoring for Antipsychotic Use
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

A resident with depression and delusional disorders was prescribed Olanzapine for delusions, but the MAR and care plan showed no targeted behavior monitoring or other behavioral documentation to support the medication’s use or effectiveness. The SS Director and DNS both confirmed the resident was not on behavior monitoring, despite the facility stating residents on antipsychotics were placed on it.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Antipsychotic Use Lacked Documented Diagnosis Support
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

A resident with severe dementia and behavioral symptoms received Seroquel with multiple dose increases, but the orders did not include a documented diagnosis to justify use or escalation. The chart showed dementia, agitation, and later psychosis documentation, while staff described the resident as generally directable and pleasant with more evening behaviors. The resident also had falls during the stay, including one that led to ER transfer.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
PRN Lorazepam Lacked Required Stop Date and Rationale
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

A resident with anxiety, restlessness, agitation, and moderately impaired cognition received PRN lorazepam for anxiety, but the order had no stop date and the EHR lacked a documented duration with physician rationale for continued use. The psychotropic care plan did not address the PRN lorazepam, and an RN verified the facility had not obtained the required 14-day stop date or documentation for ongoing use.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Incomplete Psychotropic Behavior Monitoring and Orthostatic BP Documentation
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

Incomplete Psychotropic Monitoring Documentation: The facility did not complete or accurately document monthly behavior summaries for a resident receiving Ativan, quetiapine, risperidone, and sertraline, and another resident’s behavior summary for lurasidone HCl and fluoxetine HCl was inaccurate compared with the MAR. The same resident also lacked complete orthostatic BP monitoring documentation, as the required sitting readings were not recorded within the appropriate time frame. The SSD and DON verified the missing and incorrect documentation.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Psychotropic Medication Consent and GDR Documentation Failure
E
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

A resident with CVA and dementia, and severe cognitive impairment, received trazodone for depression without a completed medication consent form before the medication was administered. The record also showed a pharmacist-recommended GDR was declined with documentation that family routinely declines GDRs, but the rationale did not state that a further dose reduction would likely impair function or cause psychiatric instability, as required.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Citation search

Search every citation & Plan of Correction

Go to search
Citation watch

Track new serious citations across New York

Get a heads-up on the newest immediate-jeopardy (J–L) citations in New York — where surveyors are focused right now.

Free · about one email a month

Trusted data from CMS and state health departments

Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.

In your survey window? See what surveyors are citing.

The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.

Get the Survey-Prep Report
An unhandled error has occurred. Reload 🗙

Connection lost — reconnecting… We couldn't reconnect automatically. Please reload the page to continue.